DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / T•••••• B••••••••• I•••
T•••••• B••••••••• I•••
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- $9.0Msum of rounds with a disclosed amount only
- Named investors
- 3
Financing history
2 rounds
- Jul 16, 2026Funding round · $9.0M (disclosed)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “TRELLIS BIOSCIENCE RAISES $9 MILLION TO ADVANCE CLINICAL DEVELOPMENT OF CALPURBATUG (TRL1068)”
- Jan 30, 2026Form D equity offering · $6.1M (form d sold) · 16 investorsFact SEC EDGAR Form D data sets (quarterly) · “T•••••• B••••••••• I••• filed Form D: $6,093,000 sold (indefinite offering), Biotechnology”
Investors on record
4 edges
- N•• M••••••••• L•• portfolio listing Fact newscienceventures.com
- D••••• G•••• o• D••••• round, participant Fact prnewswire.com
- E••••• C•••••• round, participant Fact prnewswire.com
- N•• M••••••••• L•• round, participant Fact prnewswire.com
People
5 officers, 0 directors
- E•••••••• W•••••• Chief Operating Officer sec.gov
- G•••• D••••• Chief Business Officer sec.gov
- L•••• K••••• Chief Science Officer sec.gov
- N••• M•••• Chief Financial Officer sec.gov
- S••••• R•••• President and Chief Executive Officer sec.gov
Timeline
2
- Jul 16, 2026TRELLIS BIOSCIENCE announced Funding round of $9,000,000Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
- May 15, 2026T•••••• B••••••••• I••• filed Form D: $6,093,000 sold (indefinite offering), BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
18 observations
Every observation on this company
- Entity type: Corporation May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $6.1M May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-01-30 May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Indefinite offering: true May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 16 May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering other type: Series C Interests May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 702 Marshall Street, Suite 301, Redwood City, CA, 94063 May 15, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: N•• M••••••••• L•• Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: N•• M••••••••• L•• Sep 12, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Round announced: Funding round $9,000,000 Jul 16, 2026 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)